FindTrial
Sign In

Postoperative Myofunctional Therapy Enhances Surgical Outcomes in Patients with Obstructive Sleep Apnea: A Prospective Comparative Study

The validation and application of myofunc-tional therapy in sleep medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110368
Enrollment
Unknown
Registered
2025-10-13
Start date
2020-02-18
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Interventions

Control Group:Surgery alone (OP)
Trial Group:Postoperative myofunctional therapy (OP+MFT)

Sponsors

Taipei Medical University-Shuang Ho Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Research Population: Adults aged 20-65 with moderate-to-severe OSA (AHI >=15 events/hour) confirmed by PSG. Inclusion Criteria: 1. Age 20-65 years.; 2. Moderate-to-severe OSA (AHI >= 15 events/hour) ; 3. Friedman palate position grade I-II and tonsil size grade III-IV; 4. Patients who refuse or are unable to tolerate CPAP.

Exclusion criteria

Exclusion criteria: 1. Central or mixed sleep apnea. 2. BMI > 27 kg/m^2. 3. Severe cardiopulmonary disease or psychiatric illness. 4. Pregnancy or cancer. 5. Significant weight gain during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Change in Apnea-Hypopnea Index (AHI);—

Secondary

MeasureTime frame
Change in LSaO2 and Snore index;—

Countries

China

Contacts

Public ContactChengjung Wu

Shuang Ho Hospital, Taipei Medical University

cjwu@tmu.edu.tw+886 2 2249 0088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026